GARO H. ARMEN - 02 Feb 2022 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Chairman and CEO, Director
Signature
/s/ Garo H. Armen
Issuer symbol
AGEN
Transactions as of
02 Feb 2022
Net transactions value
+$594,898
Form type
4
Filing time
04 Feb 2022, 16:50:20 UTC
Previous filing
04 Jan 2022
Next filing
09 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGEN Common Stock Award $594,898 +237,011 +31% $2.51 1,007,784 02 Feb 2022 Direct F1, F2
holding AGEN Common Stock 125,969 02 Feb 2022 See Footnote F3
holding AGEN Common Stock 579,000 02 Feb 2022 See Footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the executive's 2021 performance bonus award paid in Agenus Stock. The stock issued is fully-vested on the date of issuance but is subject to a 6-month lockup restriction with 25% of the award released on the 3-month anniversary of the issuance date and 75% of the award released on the 6-month anniversary.
F2 $2.51 was the fair market value of our Common Stock on February 2, 2022, the stock issuance date.
F3 Shares are held in Dr. Armen's IRA accounts.
F4 Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 479,000 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 100,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.